Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial

Journal of Medical Virology
Fuyuaki IdeAikichi Iwamoto

Abstract

Immune response enhanced by therapeutic HIV-1 vaccine may control viral proliferation after discontinuation of highly active antiretroviral therapy (HAART). Although which strategies for therapeutic vaccination are feasible remains controversial, application of dendritic cells (DCs) as a vaccine adjuvant represents a promising approach to improving deteriorated immune function in HIV-1-infected individuals. The safety and efficacy of DC-based vaccine loaded with HIV-1-derived cytotoxic T lymphocytes (CTL) peptides were thus investigated in this study. Autologous DCs loaded with seven CTL peptides with HLA-A*2402 restriction were immunized to four HIV-1-infected individuals under HAART. In terms of safety, peptide-loaded DCs were well tolerated, and only mild local and general symptoms were observed during vaccine administration. ELISPOT assays to detect IFN-gamma production in CD8(+) lymphocytes revealed a limited breadth of responses to immunized peptides in two of four participants, but no response in the remaining two participants. Differences in immunological response might be attributable to the fact that responders displayed higher nadir CD4 counts before starting HAART and were immunized with a larger number of DCs per r...Continue Reading

Associated Clinical Trials

References

Mar 1, 1986·Human Immunology·S K FoungF C Grumet
Jun 3, 2000·Annual Review of Immunology·J BanchereauK Palucka
Apr 20, 2001·Nature·A J McMichael, S L Rowland-Jones
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Annette OxeniusRodney E Phillips
Apr 12, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tatsuyoshi KawamuraAndrew Blauvelt
May 28, 2003·Archives of Internal Medicine·Catherine FagardUNKNOWN Swiss HIV Cohort Study
Apr 8, 2004·Vaccine·Ann-Charlotte BoströmBritta Wahren
Nov 5, 2004·PLoS Medicine·Daniel E KaufmannBruce D Walker
Nov 30, 2004·Nature Medicine·Wei LuJean-Marie Andrieu
Jan 1, 2005·AIDS·Julianna LisziewiczFranco Lori
Apr 2, 2005·Nature Reviews. Immunology·Jacques Banchereau, A Karolina Palucka
Jul 20, 2005·The Journal of Infectious Diseases·Sabine Kinloch-de LoesUNKNOWN QUEST Study Group

❮ Previous
Next ❯

Citations

Mar 5, 2008·Cancer Immunology, Immunotherapy : CII·Dirk Nagorsen, Eckhard Thiel
Mar 15, 2012·Current HIV/AIDS Reports·Meagan O'Brien, Martin Markowitz
May 13, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Winni De HaesEllen Van Gulck
Jan 15, 2011·The Journal of Infectious Diseases·Felipe GarcíaUNKNOWN DCV2/MANON07- AIDS Vaccine Research Objective Study Group
Jan 4, 2013·Science Translational Medicine·Felipe GarcíaUNKNOWN DCV2/MANON07-ORVACS Study Group
Jul 20, 2010·Immunotherapy·Telma Miyuki OshiroAlberto José da Silva Duarte
Jul 20, 2010·Immunotherapy·Jean-Pierre Routy, Charles Nicolette
Feb 17, 2011·Immunotherapy·June Myung Kim, Sang Hoon Han
Dec 20, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Sabine D AllardRob A Gruters
Oct 23, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Henrik N KloverprisAnders Fomsgaard
Dec 20, 2008·Journal of Internal Medicine·C R Rinaldo
Sep 16, 2006·Immunological Reviews·Yuri Persidsky, Larisa Poluektova
Jun 19, 2013·Immunological Reviews·Elizabeth Miller, Nina Bhardwaj
Jun 19, 2013·Immunological Reviews·Guislaine Carcelain, Brigitte Autran
Nov 6, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jean-Pierre RoutyRafick-Pierre Sékaly
Feb 26, 2015·Human Vaccines & Immunotherapeutics·Kenneth E UgenJuan Sanchez-Ramos
Aug 6, 2013·Human Vaccines & Immunotherapeutics·Felipe GarcíaTeresa Gallart
May 29, 2012·Human Vaccines & Immunotherapeutics·Felipe GarcíaTeresa Gallart
Dec 22, 2014·Annales pharmaceutiques françaises·A L de GoedeR A Gruters
Nov 30, 2016·International Journal of Molecular Sciences·Antonio Victor Campos CoelhoSergio Crovella
Apr 23, 2017·Expert Review of Vaccines·Lorna LealFelipe García
Feb 7, 2008·Expert Review of Vaccines·Andreas Boberg, Maria Isaguliants
Nov 13, 2015·Journal of the International AIDS Society·Gina M Graziani, Jonathan B Angel
Jan 1, 2007·Current Opinion in HIV and AIDS·Christian B Willberg, Douglas F Nixon
Jul 14, 2010·Expert Review of Vaccines·William K Decker, Amar Safdar
Aug 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sarah McCormickZhou Xing
Apr 15, 2008·Experimental Biology and Medicine·Moiz KitabwallaJames E K Hildreth
Jan 9, 2019·Frontiers in Immunology·Laís Teodoro da SilvaTelma Miyuki Oshiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.